Respiratory Multiplex Assay

About New Day Diagnostics

New Day Diagnostics is an emerging, vertically integrated diagnostics company with a dual-pronged business model. It commercially offers ColoHealth, a blood-based test for colorectal cancer (CRC) screening with a validated 99.7% Negative Predictive Value (NPV), and provides diagnostic Contract Research Organization (CRO) services to other developers. The company is pursuing aggressive growth through strategic mergers, like EDP Biotech, and partnerships to expand its commercial footprint and pipeline into other cancers and infectious diseases. Its operations are supported by a CLIA-certified, ISO 13485-accredited laboratory, underpinning both its product commercialization and service offerings.

Therapeutic Areas